Literature DB >> 21781360

Management of acute intestinal failure.

Keith R Gardiner1.   

Abstract

Intestinal failure (IF) occurs when intestinal absorptive function is inadequate to maintain hydration and nutrition without enteral or parenteral supplements. It has been classified into three types depending on duration of nutrition support and reversibility. Type 1 IF is commonly seen in the peri-operative period as ileus and usually spontaneously resolves within 14 d. Type 2 IF is uncommon and is often associated with an intra-abdominal catastrophe, intestinal resection, sepsis, metabolic disturbances and undernutrition. Type 3 IF is a chronic condition in a metabolically stable patient, which usually requires long-term parenteral nutrition. This paper focuses on Types 1 and 2 IF (or acute IF) that are usually found in surgical wards. The objectives of this paper are to review the incidence, aetiology, prevention, management principles and outcome of acute IF. The paper discusses the resources necessary to manage acute IF, the indications for inter-hospital transfer and the practicalities of how to transfer and receive a patient with acute IF.

Entities:  

Mesh:

Year:  2011        PMID: 21781360     DOI: 10.1017/S0029665111000504

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  3 in total

Review 1.  Management of Intestinal Failure: The High-Output Enterostomy and Enterocutaneous Fistula.

Authors:  Franklin Adaba; Carolynne J Vaizey; Janindra Warusavitarne
Journal:  Clin Colon Rectal Surg       Date:  2017-05-22

2.  Enteral Autonomy with Teduglutide Treatment of Intestinal Failure/Short Bowel Syndrome with Depleted Central Venous Access.

Authors:  Mohammad M Jami; Russell J Merritt
Journal:  Dig Dis Sci       Date:  2017-10-09       Impact factor: 3.199

Review 3.  Assessment and management of patients with intestinal failure: a multidisciplinary approach.

Authors:  Jennie T Grainger; Yasuko Maeda; Suzanne C Donnelly; Carolynne J Vaizey
Journal:  Clin Exp Gastroenterol       Date:  2018-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.